Tadalafil Tablet
Product Images NDC 68071-3753
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 68071-3753). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
F35596a7-figure-01 (F35596a7 Figure 01)
F35596a7-figure-02 (F35596a7 Figure 02)
F35596a7-figure-03 (F35596a7 Figure 03)
F35596a7-figure-04 (F35596a7 Figure 04)
F35596a7-figure-05 (F35596a7 Figure 05)
F35596a7-figure-06 (F35596a7 Figure 06)
F35596a7-figure-07 (F35596a7 Figure 07)
F35596a7-figure-08 (F35596a7 Figure 08)
F35596a7-figure-09 (F35596a7 Figure 09)
This text seems to provide information related to a study or experiment involving Tadalafil tablets at 5 mg compared to a placebo. The results indicate a statistically significant difference with a p-value less than 0.01. The graph illustrates the duration of treatment in weeks along with the corresponding effects observed.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.